Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Changes in symptoms and lifestyle factors in patients seeking healthcare for gastrointestinal symptoms: an 18-year follow-up study.

Stake-Nilsson K, Hultcrantz R, Unge P, Wengström Y.

Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1470-7. doi: 10.1097/MEG.0b013e328365c359.

PMID:
24067605
2.

Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome.

Lindfors P, Unge P, Nyhlin H, Ljótsson B, Björnsson ES, Abrahamsson H, Simrén M.

Scand J Gastroenterol. 2012 Apr;47(4):414-20. doi: 10.3109/00365521.2012.658858. Epub 2012 Feb 20.

PMID:
22339617
3.

Complementary and alternative medicine used by persons with functional gastrointestinal disorders to alleviate symptom distress.

Stake-Nilsson K, Hultcrantz R, Unge P, Wengström Y.

J Clin Nurs. 2012 Mar;21(5-6):800-8. doi: 10.1111/j.1365-2702.2011.03985.x. Epub 2011 Dec 17.

PMID:
22175282
4.

Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials.

Lindfors P, Unge P, Arvidsson P, Nyhlin H, Björnsson E, Abrahamsson H, Simrén M.

Am J Gastroenterol. 2012 Feb;107(2):276-85. doi: 10.1038/ajg.2011.340. Epub 2011 Oct 4.

PMID:
21971535
5.

A qualitative study of complementary and alternative medicine use in persons with uninvestigated dyspepsia.

Stake-Nilsson K, Söderlund M, Hultcrantz R, Unge P.

Gastroenterol Nurs. 2009 Mar-Apr;32(2):107-14. doi: 10.1097/SGA.0b013e31819e4be7.

PMID:
19357474
6.

Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.

Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, Grännö C, Ung KA, Hjortswang H, Lindgren A, Unge P.

Scand J Gastroenterol. 2009;44(7):838-45. doi: 10.1080/00365520902839667.

PMID:
19330567
7.

Approach to managing undiagnosed chest pain: could gastroesophageal reflux disease be the cause?

Flook N, Unge P, Agréus L, Karlson BW, Nilsson S.

Can Fam Physician. 2007 Feb;53(2):261-6. Review. Erratum in: Can Fam Physician. 2007 Jul;53(7):1148.

8.

Sensed presence and mystical experiences are predicted by suggestibility, not by the application of transcranial weak complex magnetic fields.

Granqvist P, Fredrikson M, Unge P, Hagenfeldt A, Valind S, Larhammar D, Larsson M.

Neurosci Lett. 2005 Apr 29;379(1):1-6.

PMID:
15849873
9.

Comparison of gastric histology among Swedish and Japanese patients with peptic ulcer and Helicobacter pylori infection.

Kimura K, Sipponen P, Unge P, Ekström P, Satoh K, Hellblom M, Ohlin B, Stubberöd A, Kihira K, Yube T, Yoshida Y.

Scand J Gastroenterol. 2003 May;38(5):491-7.

PMID:
12795458
10.

Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features?

Unge P, Kimura K, Sipponen P, Ekström P, Satoh K, Hellblom M, Ohlin B, Stubberöd A, Kihira K, Yube T, Yoshida Y.

Scand J Gastroenterol. 2003 May;38(5):482-90.

PMID:
12795457
11.

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

Bolling-Sternevald E, Lauritsen K, Aalykke C, Havelund T, Knudsen T, Unge P, Ekström P, Jaup B, Norrby A, Stubberöd A, Melén K, Carlsson R, Jerndal P, Junghard O, Glise H.

Scand J Gastroenterol. 2002 Dec;37(12):1395-402.

PMID:
12523588
12.

Comparison of Gastric Histology Among Swedish and Japanese Patients with Peptic Ulcer and <emph type="2">Helicobacter pylori</emph> Infection.

Kimura K, Sipponen P, Unge P, Ekström P, Satoh K, Hellblom M, Ohlin B, Stubberöd A, Kihira K, Yube T, Yoshida Y.

Scand J Gastroenterol. 2003;38(5):491-497. doi: 10.1080/00365520310000366.

PMID:
28443767
13.

Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis.

Lindgren S, Löfberg R, Bergholm L, Hellblom M, Carling L, Ung KA, Schiöler R, Unge P, Wallin C, Ström M, Persson T, Suhr OB.

Scand J Gastroenterol. 2002 Jun;37(6):705-10.

PMID:
12126250
14.

Symposium: Helicobacter pylori and clinical risks--focus on gastro-oesophageal reflux disease.

Malfertheiner P, O'Connor HJ, Genta RM, Unge P, Axon AT.

Aliment Pharmacol Ther. 2002 Jun;16 Suppl 3:1-10.

15.

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study.

Mégraud F, Lehn N, Lind T, Bayerdörffer E, O'Morain C, Spiller R, Unge P, van Zanten SV, Wrangstadh M, Burman CF.

Antimicrob Agents Chemother. 1999 Nov;43(11):2747-52.

16.

The OAC and OMC options.

Unge P.

Eur J Gastroenterol Hepatol. 1999 Aug;11 Suppl 2:S9-17; discussion S23-4.

PMID:
10503817
17.

The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer.

Malfertheiner P, Bayerdörffer E, Diete U, Gil J, Lind T, Misiuna P, O'Morain C, Sipponen P, Spiller RC, Stasiewicz J, Treichel H, Ujszászy L, Unge P, Zanten SJ, Zeijlon L.

Aliment Pharmacol Ther. 1999 Jun;13(6):703-12.

18.

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.

Zanten SJ, Bradette M, Farley A, Leddin D, Lind T, Unge P, Bayerdörffer E, Spiller RC, O'Morain C, Sipponen P, Wrangstadh M, Zeijlon L, Sinclair P.

Aliment Pharmacol Ther. 1999 Mar;13(3):289-95.

19.

Antibiotic treatment of Helicobacter pylori infection.

Unge P.

Curr Top Microbiol Immunol. 1999;241:261-300. Review. No abstract available.

PMID:
10087665
20.
21.

The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.

Lind T, Mégraud F, Unge P, Bayerdörffer E, O'morain C, Spiller R, Veldhuyzen Van Zanten S, Bardhan KD, Hellblom M, Wrangstadh M, Zeijlon L, Cederberg C.

Gastroenterology. 1999 Feb;116(2):248-53.

PMID:
9922303
24.

What other regimens are under investigation to treat Helicobacter pylori infection?

Unge P.

Gastroenterology. 1997 Dec;113(6 Suppl):S131-48. Review.

PMID:
9394775
25.

Drug interactions with proton pump inhibitors.

Unge P, Andersson T.

Drug Saf. 1997 Mar;16(3):171-9. Review.

PMID:
9098655
26.

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.

Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdörffer E, O'Morain C, Bardhan KD, Bradette M, Chiba N, Wrangstadh M, Cederberg C, Idström JP.

Helicobacter. 1996 Sep;1(3):138-44.

PMID:
9398894
27.

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.

Ekström P, Carling L, Wetterhus S, Wingren PE, Anker-Hansen O, Lundegårdh G, Thorhallsson E, Unge P.

Scand J Gastroenterol. 1996 Aug;31(8):753-8.

PMID:
8858742
28.

Pooled analysis of anti-Helicobacter pylori treatment regimens.

Unge P, Berstad A.

Scand J Gastroenterol Suppl. 1996;220:27-40. Review.

PMID:
8898433
29.

Review of Helicobacter pylori eradication regimens.

Unge P.

Scand J Gastroenterol Suppl. 1996;215:74-81.

PMID:
8722388
30.
31.

Lansoprazole versus omeprazole in active duodenal ulcer. A double-blind, randomized, comparative study.

Ekström P, Carling L, Unge P, Anker-Hansen O, Sjöstedt S, Sellström H.

Scand J Gastroenterol. 1995 Mar;30(3):210-5.

PMID:
7770708
32.

Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.

Hallerbäck B, Unge P, Carling L, Edwin B, Glise H, Havu N, Lyrenäs E, Lundberg K.

Gastroenterology. 1994 Nov;107(5):1305-11.

PMID:
7926494
33.
34.

[Choice of therapy (Helicobacter infection)].

Danielsson A, Jaup B, Unge P.

Lakartidningen. 1994 May 11;91(19):1928-30. Swedish. No abstract available.

PMID:
8189940
35.

[A new clinical strategy in peptic ulcer disease. Suggestions for the elimination of Helicobacter pylori].

Unge P, Ekström P.

Lakartidningen. 1994 May 11;91(19):1925-32. Swedish. No abstract available.

PMID:
8189937
36.

Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial.

Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P, Ekström P, Halvorsen L, Stallemo A, Hovdenak N, Trondstad R, et al.

Scand J Gastroenterol. 1993 Mar;28(3):224-8.

PMID:
8446846
37.

A study of the interaction of omeprazole and warfarin in anticoagulated patients.

Unge P, Svedberg LE, Nordgren A, Blom H, Andersson T, Lagerström PO, Idström JP.

Br J Clin Pharmacol. 1992 Dec;34(6):509-12.

38.
39.

Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research.

Glise H, Martinson J, Solhaug JH, Carling L, Unge P, Engström G, Hallerbäck B.

Scand J Gastroenterol. 1991 Feb;26(2):137-45.

PMID:
2011700
40.

A study of the interaction between omeprazole and phenytoin in epileptic patients.

Andersson T, Lagerström PO, Unge P.

Ther Drug Monit. 1990 Jul;12(4):329-33.

PMID:
2396305
41.

Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

Lundell L, Backman L, Ekström P, Enander LH, Fausa O, Lind T, Lönroth H, Sandmark S, Sandzén B, Unge P, et al.

Aliment Pharmacol Ther. 1990 Apr;4(2):145-55.

PMID:
1983321
42.

Campylobacter pylori: Swedish experiences.

Unge P, Gnarpe H, Blomqvist C.

Scand J Gastroenterol Suppl. 1989;157:12-5; discussion 21-2.

PMID:
2665049
43.
44.

Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study.

Carling L, Cronstedt J, Engqvist A, Kagevi I, Nyström B, Svedberg LE, Thorhallsson E, Unge P, Wingren PE.

Scand J Gastroenterol. 1988 Nov;23(9):1117-24.

PMID:
3073524
45.

Campylobacter pylori in Swedish patients referred for gastroscopy.

Gnarpe H, Unge P, Blomqvist C, Mäkitalo S.

APMIS. 1988 Feb;96(2):128-32.

PMID:
2449900
47.

Enprostil and cimetidine: comparative efficacy and safety in patients with duodenal ulcer.

Carling L, Unge P, Almström C, Cronstedt J, Ekström P, Hägg S, Hansson B.

Scand J Gastroenterol. 1987 Apr;22(3):325-31.

PMID:
3109017
48.

[Phenytoin causing an isolated increase in glutamyl transpeptidase].

Unge P.

Lakartidningen. 1983 Aug 24;80(34):2974-6. Swedish. No abstract available.

PMID:
6138498

Supplemental Content

Support Center